Onconova Therapeutics DSO Ratio 2011-2026 | ONTX

Annual DSO Ratio Onconova Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
364	1.44 K	38	46	52.5	-	16.4	10.4	27.4	2.04	47.9	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.44 K	2.04	204

Quarterly DSO Ratio Onconova Therapeutics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.94 K	-	49.7	2.74 K	-	1.7 K	14.4	29.3	-	28	27.2	37.5	-	44.8	44	44.8	-	44.8	52	61.1	-	51.2	60.3	118	-	142	4.42	89.2	-	26.6	6.59	7.6	-	48.9	16.6	19.6	-	1.71	1.26	47.5	-	84.6	1.12 K	655	106	52.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.94 K	1.26	300

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	99.7	$ 3.14	0.16 %	$ 653 M	USA
Eton Pharmaceuticals ETON	39.1	$ 35.13	1.97 %	$ 945 M	USA
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.66	2.47 %	$ 442 M	Britain
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	198	$ 0.87	2.78 %	$ 145 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	400	$ 2.61	-3.7 %	$ 244 M	Israel
Incyte Corporation INCY	66.6	$ 97.69	0.63 %	$ 19.1 B	USA
Anika Therapeutics ANIK	76.5	$ 15.09	-0.33 %	$ 216 M	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Ionis Pharmaceuticals IONS	20.5	$ 75.94	1.17 %	$ 12.2 B	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.4	2.41 %	$ 5.6 M	Israel
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	559	$ 1.6	5.61 %	$ 187 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	106	$ 20.88	2.0 %	$ 2.66 B	USA